{"title":"COVID-19给quire .ai带来的机遇","authors":"R. Roy","doi":"10.1177/14657503211063913","DOIUrl":null,"url":null,"abstract":"Qure.ai was a healthcare startup deep learning, a subset of machine learning, in healthcare. One of their products was used to diagnose tuberculosis and other lung ailments. With the spread of COVID-19, they were able to repurpose their product to also detect early onset of COVID-19 in patients. They were in a position where they had to decide whether to focus on COVID-19 or on the opportunities related to other lung ailments.","PeriodicalId":126058,"journal":{"name":"The International Journal of Entrepreneurship and Innovation","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The COVID-19 opportunity for Qure.ai\",\"authors\":\"R. Roy\",\"doi\":\"10.1177/14657503211063913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Qure.ai was a healthcare startup deep learning, a subset of machine learning, in healthcare. One of their products was used to diagnose tuberculosis and other lung ailments. With the spread of COVID-19, they were able to repurpose their product to also detect early onset of COVID-19 in patients. They were in a position where they had to decide whether to focus on COVID-19 or on the opportunities related to other lung ailments.\",\"PeriodicalId\":126058,\"journal\":{\"name\":\"The International Journal of Entrepreneurship and Innovation\",\"volume\":\"46 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The International Journal of Entrepreneurship and Innovation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/14657503211063913\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of Entrepreneurship and Innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/14657503211063913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Qure.ai was a healthcare startup deep learning, a subset of machine learning, in healthcare. One of their products was used to diagnose tuberculosis and other lung ailments. With the spread of COVID-19, they were able to repurpose their product to also detect early onset of COVID-19 in patients. They were in a position where they had to decide whether to focus on COVID-19 or on the opportunities related to other lung ailments.